• Webinar Details

  • Home / Learn / Live CE / Live CE Event Calendar / Webinar Details


New Treatment Options for T2D - A Focus on Glycemic Control and Lowering CV Risk

Event Type

Live Online

Date

Wednesday, February 13, 2019

Time

10:30 AM - 12:30 PM ET

Location

PharmCon Webinar Studio (freeCE.com)

Credits

2 Contact Hour(s)

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$45.00

  • Overview

    Patients with diabetes are also much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes – certainly a medical double jeopardy. The American Diabetes Association’s (ADA) recently published the 2017 Standards of Medical Care in Diabetes and included new recommendations on treating both diabetes and cardiovascular disease. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmaco-therapy and individualized treatment. This program will review the ADA’s latest update to the Standards of Medical Care in Diabetes, review recent outcomes trials of antihyperglycemic therapies in patients with type 2 diabetes (T2D) and outline evidence based treatment strategies to mitigate the risk of cardiovascular disease in patients with T2D. 

    Rating


    Handouts

    Slide Document:   18265L01_6pp.pdf


    Slide Document:   18265L01_2pp.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Summarize the ADA and AACE guidelines with respect to efficacy and safety particularly when analyzing cardiovascular and renal outcomes
    Recognize the drug therapies and show evidence of benefit in improving blood sugars and decreasing risk of cardiovascular and renal events
    Identify guidelines that are recommended by the ADA and AACE for CV risk reduction and the others in this class


    Pharmacist

    Summarize the ADA and AACE guidelines with respect to efficacy and safety particularly when analyzing cardiovascular and renal outcomes
    Recognize the drug therapies and show evidence of benefit in improving blood sugars and decreasing risk of cardiovascular and renal events
    Identify guidelines that are recommended by the ADA and AACE for CV risk reduction and the others in this class


    Pharmacy Technician

    Review how different treatment options work to lower blood sugar levels in patients with diabetes
    Recognize the effects of diabetes agents on glycosylated hemoglobin levels (A1c)
    List some common safety concerns about different agents used to treat type 2 diabetes

  • Repeat Presentation

    This is a first run presentation.

    Future Airings

    DateTime 
    Wednesday, May 1, 20198:00 PMView

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-18-265-L01-N

    Pharmacist 0798-0000-18-265-L01-P

    Pharmacy Technician 0798-0000-18-265-L01-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

  • Faculty

    Tamara Goldberg, PharmD, BCPS
    Associate Professor of Pharmacy Practice, Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University




HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.